个人中心 - 老虎社区

BSBGS

IP属地：未知

帖子 · 11帖子 · 11
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- BSBGSBSBGS
  ·2021-10-04
  Like
  What to know this week：September jobs report, PepsiCo and Levi earnings<blockquote>本周需要了解的内容：9月份就业报告、百事可乐和李维斯收益</blockquote>
  The spotlight this week for Wall Street will be on labor market data, as investors await the release
  What to know this week：September jobs report, PepsiCo and Levi earnings<blockquote>本周需要了解的内容：9月份就业报告、百事可乐和李维斯收益</blockquote>
  1,503 2
  5
  分享
  举报
- BSBGSBSBGS
  ·2021-10-02
  up
  非常抱歉，此主贴已删除
  1,059 评论
  4
  分享
  举报
- BSBGSBSBGS
  ·2021-10-01
  Like
  非常抱歉，此主贴已删除
  1,798 评论
  3
  分享
  举报
- BSBGSBSBGS
  ·2021-09-29
  Ok
  Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Falling Tuesday<blockquote>为什么辉瑞、BioNTech、Moderna和Novavax股价周二下跌</blockquote>
  Investors seem increasingly jittery about the future prospects for COVID-19 vaccines. Key Points P
  Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Falling Tuesday<blockquote>为什么辉瑞、BioNTech、Moderna和Novavax股价周二下跌</blockquote>
  1,651 1
  2
  分享
  举报
- BSBGSBSBGS
  ·2021-09-19
  $Apple(AAPL)$[财迷]
  2,187 评论
  点赞
  分享
  举报
- BSBGSBSBGS
  ·2021-09-18
  Hdhjs
  非常抱歉，此主贴已删除
  911 1
  4
  分享
  举报
- BSBGSBSBGS
  ·2021-09-18
  up
  非常抱歉，此主贴已删除
  497 1
  7
  分享
  举报
- BSBGSBSBGS
  ·2021-09-16
  Power
  非常抱歉，此主贴已删除
  885 评论
  点赞
  分享
  举报
- BSBGSBSBGS
  ·2021-09-16
  $Apple(AAPL)$up
  684 评论
  点赞
  分享
  举报
- BSBGSBSBGS
  ·2021-09-15
  $Apple(AAPL)$🥰🥰🥰
  663 评论
  点赞
  分享
  举报

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4089378841570750","uuid":"4089378841570750","gmtCreate":1626275778738,"gmtModify":1626275778738,"name":"BSBGS","pinyin":"bsbgs","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":52,"tweetSize":11,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.11.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":867570400,"gmtCreate":1633304675484,"gmtModify":1633304725441,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/867570400","repostId":"2172203962","repostType":4,"repost":{"id":"2172203962","kind":"news","pubTimestamp":1633284334,"share":"https://www.laohu8.com/m/news/2172203962?lang=zh_CN&edition=full","pubTime":"2021-10-04 02:05","market":"us","language":"en","title":"What to know this week：September jobs report, PepsiCo and Levi earnings<blockquote>本周需要了解的内容：9月份就业报告、百事可乐和李维斯收益</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2172203962","media":"Yahoo Finance","summary":"The spotlight this week for Wall Street will be on labor market data, as investors await the release","content":"<p><div> The spotlight this week for Wall Street will be on labor market data, as investors await the release of the Labor Department's September jobs report on Friday. Several earnings results from major ...</p><p><blockquote><div>本周华尔街的焦点将是劳动力市场数据，投资者等待劳工部周五发布的9月份就业报告。主要公司的几项盈利结果...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/september-jobs-report-pepsi-co-and-levi-earnings-what-to-know-this-week-180534292.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/september-jobs-report-pepsi-co-and-levi-earnings-what-to-know-this-week-180534292.html\">网页连接</a></blockquote></p><p></p>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What to know this week：September jobs report, PepsiCo and Levi earnings<blockquote>本周需要了解的内容：9月份就业报告、百事可乐和李维斯收益</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat to know this week：September jobs report, PepsiCo and Levi earnings<blockquote>本周需要了解的内容：9月份就业报告、百事可乐和李维斯收益</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yahoo Finance</strong><span class=\"h-time small\">2021-10-04 02:05</span>\n</p>\n</h4>\n</header>\n<article>\n<p><div> The spotlight this week for Wall Street will be on labor market data, as investors await the release of the Labor Department's September jobs report on Friday. Several earnings results from major ...</p><p><blockquote><div>本周华尔街的焦点将是劳动力市场数据，投资者等待劳工部周五发布的9月份就业报告。主要公司的几项盈利结果...</div></blockquote></p><p>  <a href=\"https://finance.yahoo.com/news/september-jobs-report-pepsi-co-and-levi-earnings-what-to-know-this-week-180534292.html\">网页链接</a>  </div> </p><p><blockquote><a href=\"https://finance.yahoo.com/news/september-jobs-report-pepsi-co-and-levi-earnings-what-to-know-this-week-180534292.html\">网页连接</a></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://finance.yahoo.com/news/september-jobs-report-pepsi-co-and-levi-earnings-what-to-know-this-week-180534292.html\">Yahoo Finance</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PEP":"百事可乐",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/september-jobs-report-pepsi-co-and-levi-earnings-what-to-know-this-week-180534292.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2172203962","content_text":"The spotlight this week for Wall Street will be on labor market data, as investors await the release of the Labor Department's September jobs report on Friday. Several earnings results from major consumer brands are also on tap, and OPEC+.\nAll eyes are focused on the meeting of OPEC+（ the group of oil producers）to be held on October 4.The group had been widely expected to keep current plans to raise overall production by 400,000 barrels a day each month in place.On last Thursday, Reuters reported that the Organization of the Petroleum Exporting Countries and its allies, including Russia, known as OPEC+, is weighing additional production increases, \"beyond its existing deal to boost production by 400,000 barrels per day,\" as prices for crude trade near year three-year highs.\nTraders are looking to see payroll gains accelerate in Septembe after a shockingly disappointing August jobs report, when just 235,000 jobs came back versus the more than 700,000 expected. Consensus economists anticipate that 475,000 payrolls returned in September, and that the unemployment rate fell to 5.1%, or the lowest since March 2020.\n\"There is more hope for the labor market. The next few months will be important and we could see greater labor market participation as fear of the virus abates,\" Bank of America U.S. economist Michelle Meyer wrote in a note on Friday.\nMeyer also flagged recent comments from Federal Reserve Governor Lael Brainard, who addressed some of the ongoing labor scarcities and issues in bringing individuals back into the workforce.\n\"The decline in labor force participation appears to reflect COVID-related constraints that have been prolonged by Delta rather than permanent structural changes in the economy,\" Brainard said in public remarks in Arlington, Va., last week.\nBut these virus-related risks still remain a point of concern for the labor market's recovery, and for the September jobs report in particular. And the U.S. economy has still lost a net total of over 5 million payrolls since March 2020, underscoring the deficit still left to recoup on employment.\n\"To the downside, we see risk of public payrolls contracting modestly in September as education payrolls could recede modestly due to school closures amid the Delta wave and negative payback from strong hiring over the summer,\" Meyer said. \"Consequently, we think private payrolls growth will be marginally stronger than non-farm payrolls growth. All told, the data flow suggests another soft month of employment activity but a slightly faster pace of job gains compared to August.\"\nImportantly, the September jobs report will be a key factor in informing the Federal Reserve's timing on formally announcing and beginning tapering of its pandemic-era asset purchase program. The central bank signaled last month that it believed the economy was on its way to being able to stand on its own without the extraordinary levels of monetary policy support seen over the course of the year and a half.\nAnd indeed, Fed officials have said the economy has already met the central bank's targeted threshold for inflation, and that only more progress on the labor market's recovery was needed to be enough to trigger the start of tapering.\n\"It wouldn't take a knockout, great, super strong employment report,\" Federal Reserve Chair Jerome Powell saidduring his latest post-FOMC meeting press conference in September. \"It would take a reasonably good employment report for me to feel like that test is met.\"\nConsumer names to report earnings\nA number of companies are set to report quarterly results throughout the week, offering a first look at how corporate profits have held up in the third-quarter before a bigger wave of firms report results in the coming weeks.\nThe names reporting this week will center on major consumer brands including PepsiCo (PEP), Constellation Brands (STZ) and Levi Strauss (LEVI). One of the key themes from these reports and earnings calls will be on commentary around inflation, labor and supply chain challenges, given rising prices and materials shortages already seen across various pockets of the economy.\nResults last week from companies including Bed Bath & Beyond (BBBY), for instance, already served as a harbinger of the myriad supply-side issues facing the retail industry. The company posted an unexpected drop in same-store sales for its quarter ending in late August, whereas Wall Street had projected same-store sales growth. The drop came both as a result of consumer skittishness over shopping in-person during the Delta variant's spread, and as supply pressures weighed on growth.\nWhen asked during the company earnings call whether these challenges might abate over the balance of the year, Bed Bath & Beyond CEO Mark Tritton said the company was \"not expecting supply chain pressures to ease.\"\n\"We operated under unprecedented supply chain conditions that have continued to increasingly tighten global trade since last year,\" Tritton said.\nCompanies in other industries have highlighted similar concerns. Micron (MU), the biggest domestic memory chipmaker, said in a letter to customers that it was still experiencing cost increases for materials and services and did \"not expect that pressure to ease in the foreseeable future,\" according to a report from Bloomberg last week. And earlier in September, FedEx (FDX) posted a sharp miss on quarterly profits as supply chain pressures and rising labor costs pressured margins for the shipping giant.\nEconomic calendar\n\nMonday:Factory orders, August (1.0% expected, 0.4% in July); Durable goods orders, August final (1.8% in prior print); Durable goods orders, excluding transportation, August final (0.2% in prior print); Non-defense capital goods orders, excluding aircraft, August final (0.5% in prior print); Non-defense capital goods orders, excluding aircraft, August final (0.7% in prior print)\nTuesday:Trade balance, August (-$70.5 billion expected, -$70.1 billion in July); Markit U.S. services PMI, September final (54.4 expected, 54.4 in prior print); Markit U.S. composite PMI, September final (54.5 in prior print); ISM Services index, September (60.0 expected, 61.7 in August)\nWednesday:MBA Mortgage Applications, week ended October 1 (-1.1% during prior week); ADP Employment Change, September (450,000 expected, 374,000 in August)\nThursday:Challenger Job Cuts, year-over-year, September (-86.4% in August); Initial jobless claims, week ended October 2 (349,000 expected, 362,000 during prior week); Continuing claims, week ended September 25 (2.802 million during prior week); Consumer credit, August ($18.000 billion expected, $17.004 billion in July)\nFriday:Change in non-farm payrolls, September (488,000 expected, 235,000 in August); Unemployment rate, September (5.1% expected, 5.2% in August); Average hourly earnings, month-over-month, September (0.4% expected, 0.6% in August); Average hourly earnings, year-over-year, September (4.6% expected, 4.3% in August); Labor force participation rate, September (61.7% in August); Wholesale inventories, month-over-month, August final (1.2% expected, 1.2% in prior estimate)\n\nEarnings calendar\n\nMonday:No notable reports scheduled for release\nTuesday:PepsiCo (PEP) before market open\nWednesday:Constellation Brands (STZ) before market open; Levi Strauss (LEVI) after market close\nThursday:Conagra Brands (CAG), Tilray (TLRY) before market open\nFriday:No notable reports scheduled for release","news_type":1,"symbols_score_info":{".DJI":0.9,"PEP":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":1503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864459857,"gmtCreate":1633140988530,"gmtModify":1633140988720,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"up","listText":"up","text":"up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864459857","repostId":"2172631966","repostType":4,"isVote":1,"tweetType":1,"viewCount":1059,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":864047639,"gmtCreate":1633045986544,"gmtModify":1633045986615,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/864047639","repostId":"1121656910","repostType":4,"isVote":1,"tweetType":1,"viewCount":1798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862617434,"gmtCreate":1632875349692,"gmtModify":1632875349692,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862617434","repostId":"1111572816","repostType":4,"repost":{"id":"1111572816","kind":"news","pubTimestamp":1632875079,"share":"https://www.laohu8.com/m/news/1111572816?lang=zh_CN&edition=full","pubTime":"2021-09-29 08:24","market":"us","language":"en","title":"Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Falling Tuesday<blockquote>为什么辉瑞、BioNTech、Moderna和Novavax股价周二下跌</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1111572816","media":"Motley Fool","summary":"Investors seem increasingly jittery about the future prospects for COVID-19 vaccines.\n\nKey Points\n\nP","content":"<p>  <b><a href=\"https://laohu8.com/S/ISBC\">Investors</a> seem increasingly jittery about the future prospects for COVID-19 vaccines.</b>  <b>Key <a href=\"https://laohu8.com/S/PCOM\">Points</a></b></p><p><blockquote><b><a href=\"https://laohu8.com/S/ISBC\">投资者</a>似乎对新冠肺炎疫苗的未来前景越来越紧张。</b><b>钥匙<a href=\"https://laohu8.com/S/PCOM\">点数</a></b></blockquote></p><p> <ul>  <li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>, <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>, and <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> had some good news Tuesday.</li>  <li>Vaccine stocks are falling, though, probably because of uncertainty about future demand for vaccines.</li>  <li>It's still possible that coronavirus variants could drive sustained demand for COVID-19 vaccines.</li> </ul> <b>What happened</b></p><p><blockquote><ul><li><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>，和<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>周二有一些好消息。</li><li>不过，疫苗库存正在下跌，可能是因为未来疫苗需求的不确定性。</li><li>冠状病毒变种仍有可能推动对COVID-19疫苗的持续需求。</li></ul><b>发生了什么</b></blockquote></p><p> This isn't shaping up to be a good week for the stocks of leading COVID-19 vaccine makers. Several of the stocksslipped on Monday. The downtrend continued Tuesday.</p><p><blockquote>对于领先的COVID-19疫苗制造商的股票来说，这并不是一个好的一周。周一几只股票下跌。周二继续下跌。</blockquote></p><p> Shares of<b>Pfizer</b>(NYSE:PFE)were down 1.6% at 11:27 a.m.<b>BioNTech</b>(NASDAQ:BNTX)stock had fallen 9.4%.<b>Moderna</b>'s(NASDAQ:MRNA)shares were 6.2% lower.<b>Novavax</b>(NASDAQ:NVAX)was an especially big loser, its shares having sunk 11.6%.</p><p><blockquote>本公司之股份<b>辉瑞</b>（纽约证券交易所股票代码：PFE）截至上午11:27下跌1.6%。<b>BioNTech</b>（纳斯达克：BNTX）股价下跌9.4%。<b>现代</b>（纳斯达克股票代码：MRNA）股价下跌6.2%。<b>Novavax</b>（纳斯达克：NVAX）的跌幅尤其大，其股价下跌了11.6%。</blockquote></p><p> The declines for these&nbsp;vaccine stocks&nbsp;came despite some good news for several of them. Pfizer and BioNTech submitted initial data to the U.S. Food and Drug Administration from a late-stage study of their COVID-19 vaccine in children younger than 12 years down to age 5. Indian regulators also allowed the Serum Institute of India to begin enrolling kids ages 7 to 11 in a clinical trial evaluating Novavax's COVID-19 vaccine.</p><p><blockquote>尽管其中一些疫苗股有一些好消息，但这些疫苗股还是下跌了。辉瑞和BioNTech向美国提交了初步数据。美国食品药品监督管理局对12岁至5岁儿童的新冠肺炎疫苗进行了后期研究。印度监管机构还允许印度血清研究所开始招募7至11岁的儿童参加评估Novavax COVID-19疫苗的临床试验。</blockquote></p><p> So why are the stocks falling Tuesday? It's probably because investors are becoming increasingly anxious about the prospects for COVID-19 vaccine sales. The CEOs of both Pfizer and Moderna recently predicted thatthe pandemic could end in 2022.</p><p><blockquote>那么为什么周二股市下跌呢？这可能是因为投资者对新冠疫苗销售前景越来越焦虑。辉瑞和Moderna的首席执行官最近预测，疫情可能会在2022年结束。</blockquote></p><p> Also, Pfizer announced on Monday that it's started testing a pill that could be used to prevent infection after exposure to another person with COVID-19. If Pfizer's oral drug or similar antiviral therapies become available, it could reduce the incentive for people to seek vaccination.</p><p><blockquote>此外，辉瑞公司周一宣布，它已开始测试一种药丸，该药丸可用于在接触另一名COVID-19患者后预防感染。如果辉瑞的口服药物或类似的抗病毒疗法可用，可能会降低人们寻求疫苗接种的动力。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Investors absolutely should be looking to the future to evaluate the prospects for vaccine stocks. And there is uncertainty as to whether COVID-19 vaccine sales will remain as strong as they are now in 2023 and beyond.</p><p><blockquote>投资者绝对应该展望未来来评估疫苗股的前景。2023年及以后，COVID-19疫苗销售是否会像现在一样强劲还存在不确定性。</blockquote></p><p> It's not surprising that Pfizer stock didn't fall nearly as much as shares of BioNTech, Moderna, or Novavax. The big drugmaker isn't totally dependent on its COVID-19 vaccine, as BioNTech and Moderna are -- and Novavax potentially soon will be.</p><p><blockquote>毫不奇怪，辉瑞股价的跌幅没有BioNTech、Moderna或Novavax的股价那么大。这家大型制药商并不像BioNTech和Moderna那样完全依赖其COVID-19疫苗，Novavax可能很快就会如此。</blockquote></p><p> However, there's still a possibility that emerging coronavirus variants could cause the demand for COVID-19 vaccines to remain strong for years to come. Tuesday's sell-off could turn out to be unwarranted.</p><p><blockquote>然而，新出现的冠状病毒变种仍有可能导致未来几年对新冠肺炎疫苗的需求保持强劲。周二的抛售可能是没有根据的。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Each of these stocks has key catalysts on the way. Pfizer and BioNTech hope to soon file for FDA Emergency Use Authorization for their COVID-19 vaccine in immunizing younger children. Moderna awaits a decision on booster doses. Novavax hopes to win Emergency Use Listing from the World Health Organization for its COVID-19 vaccine and plans to file for EUAs in multiple countries.</p><p><blockquote>这些股票中的每一只都有关键催化剂。辉瑞和BioNTech希望尽快向FDA申请其新冠肺炎疫苗在幼儿免疫中的紧急使用授权。Moderna正在等待加强剂量的决定。Novavax希望其COVID-19疫苗获得世界卫生组织的紧急使用清单，并计划在多个国家申请EUA。</blockquote></p><p> As long as the uncertainty about future demand for COVID-19 vaccines continues, though, look for continued volatility with all of these stocks.</p><p><blockquote>不过，只要COVID-19疫苗未来需求的不确定性持续存在，所有这些股票都将持续波动。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Pfizer, BioNTech, Moderna, and Novavax Stocks Are Falling Tuesday<blockquote>为什么辉瑞、BioNTech、Moderna和Novavax股价周二下跌</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Pfizer, BioNTech, Moderna, and Novavax Stocks Are Falling Tuesday<blockquote>为什么辉瑞、BioNTech、Moderna和Novavax股价周二下跌</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Motley Fool</strong><span class=\"h-time small\">2021-09-29 08:24</span>\n</p>\n</h4>\n</header>\n<article>\n<p>  <b><a href=\"https://laohu8.com/S/ISBC\">Investors</a> seem increasingly jittery about the future prospects for COVID-19 vaccines.</b>  <b>Key <a href=\"https://laohu8.com/S/PCOM\">Points</a></b></p><p><blockquote><b><a href=\"https://laohu8.com/S/ISBC\">投资者</a>似乎对新冠肺炎疫苗的未来前景越来越紧张。</b><b>钥匙<a href=\"https://laohu8.com/S/PCOM\">点数</a></b></blockquote></p><p> <ul>  <li><a href=\"https://laohu8.com/S/PFE\">Pfizer</a>, <a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>, and <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> had some good news Tuesday.</li>  <li>Vaccine stocks are falling, though, probably because of uncertainty about future demand for vaccines.</li>  <li>It's still possible that coronavirus variants could drive sustained demand for COVID-19 vaccines.</li> </ul> <b>What happened</b></p><p><blockquote><ul><li><a href=\"https://laohu8.com/S/PFE\">辉瑞</a>,<a href=\"https://laohu8.com/S/BNTX\">BioNTech SE</a>，和<a href=\"https://laohu8.com/S/NVAX\">Novavax</a>周二有一些好消息。</li><li>不过，疫苗库存正在下跌，可能是因为未来疫苗需求的不确定性。</li><li>冠状病毒变种仍有可能推动对COVID-19疫苗的持续需求。</li></ul><b>发生了什么</b></blockquote></p><p> This isn't shaping up to be a good week for the stocks of leading COVID-19 vaccine makers. Several of the stocksslipped on Monday. The downtrend continued Tuesday.</p><p><blockquote>对于领先的COVID-19疫苗制造商的股票来说，这并不是一个好的一周。周一几只股票下跌。周二继续下跌。</blockquote></p><p> Shares of<b>Pfizer</b>(NYSE:PFE)were down 1.6% at 11:27 a.m.<b>BioNTech</b>(NASDAQ:BNTX)stock had fallen 9.4%.<b>Moderna</b>'s(NASDAQ:MRNA)shares were 6.2% lower.<b>Novavax</b>(NASDAQ:NVAX)was an especially big loser, its shares having sunk 11.6%.</p><p><blockquote>本公司之股份<b>辉瑞</b>（纽约证券交易所股票代码：PFE）截至上午11:27下跌1.6%。<b>BioNTech</b>（纳斯达克：BNTX）股价下跌9.4%。<b>现代</b>（纳斯达克股票代码：MRNA）股价下跌6.2%。<b>Novavax</b>（纳斯达克：NVAX）的跌幅尤其大，其股价下跌了11.6%。</blockquote></p><p> The declines for these&nbsp;vaccine stocks&nbsp;came despite some good news for several of them. Pfizer and BioNTech submitted initial data to the U.S. Food and Drug Administration from a late-stage study of their COVID-19 vaccine in children younger than 12 years down to age 5. Indian regulators also allowed the Serum Institute of India to begin enrolling kids ages 7 to 11 in a clinical trial evaluating Novavax's COVID-19 vaccine.</p><p><blockquote>尽管其中一些疫苗股有一些好消息，但这些疫苗股还是下跌了。辉瑞和BioNTech向美国提交了初步数据。美国食品药品监督管理局对12岁至5岁儿童的新冠肺炎疫苗进行了后期研究。印度监管机构还允许印度血清研究所开始招募7至11岁的儿童参加评估Novavax COVID-19疫苗的临床试验。</blockquote></p><p> So why are the stocks falling Tuesday? It's probably because investors are becoming increasingly anxious about the prospects for COVID-19 vaccine sales. The CEOs of both Pfizer and Moderna recently predicted thatthe pandemic could end in 2022.</p><p><blockquote>那么为什么周二股市下跌呢？这可能是因为投资者对新冠疫苗销售前景越来越焦虑。辉瑞和Moderna的首席执行官最近预测，疫情可能会在2022年结束。</blockquote></p><p> Also, Pfizer announced on Monday that it's started testing a pill that could be used to prevent infection after exposure to another person with COVID-19. If Pfizer's oral drug or similar antiviral therapies become available, it could reduce the incentive for people to seek vaccination.</p><p><blockquote>此外，辉瑞公司周一宣布，它已开始测试一种药丸，该药丸可用于在接触另一名COVID-19患者后预防感染。如果辉瑞的口服药物或类似的抗病毒疗法可用，可能会降低人们寻求疫苗接种的动力。</blockquote></p><p> <b>So what</b></p><p><blockquote><b>那又怎样</b></blockquote></p><p> Investors absolutely should be looking to the future to evaluate the prospects for vaccine stocks. And there is uncertainty as to whether COVID-19 vaccine sales will remain as strong as they are now in 2023 and beyond.</p><p><blockquote>投资者绝对应该展望未来来评估疫苗股的前景。2023年及以后，COVID-19疫苗销售是否会像现在一样强劲还存在不确定性。</blockquote></p><p> It's not surprising that Pfizer stock didn't fall nearly as much as shares of BioNTech, Moderna, or Novavax. The big drugmaker isn't totally dependent on its COVID-19 vaccine, as BioNTech and Moderna are -- and Novavax potentially soon will be.</p><p><blockquote>毫不奇怪，辉瑞股价的跌幅没有BioNTech、Moderna或Novavax的股价那么大。这家大型制药商并不像BioNTech和Moderna那样完全依赖其COVID-19疫苗，Novavax可能很快就会如此。</blockquote></p><p> However, there's still a possibility that emerging coronavirus variants could cause the demand for COVID-19 vaccines to remain strong for years to come. Tuesday's sell-off could turn out to be unwarranted.</p><p><blockquote>然而，新出现的冠状病毒变种仍有可能导致未来几年对新冠肺炎疫苗的需求保持强劲。周二的抛售可能是没有根据的。</blockquote></p><p> <b>Now what</b></p><p><blockquote><b>现在怎么办</b></blockquote></p><p> Each of these stocks has key catalysts on the way. Pfizer and BioNTech hope to soon file for FDA Emergency Use Authorization for their COVID-19 vaccine in immunizing younger children. Moderna awaits a decision on booster doses. Novavax hopes to win Emergency Use Listing from the World Health Organization for its COVID-19 vaccine and plans to file for EUAs in multiple countries.</p><p><blockquote>这些股票中的每一只都有关键催化剂。辉瑞和BioNTech希望尽快向FDA申请其新冠肺炎疫苗在幼儿免疫中的紧急使用授权。Moderna正在等待加强剂量的决定。Novavax希望其COVID-19疫苗获得世界卫生组织的紧急使用清单，并计划在多个国家申请EUA。</blockquote></p><p> As long as the uncertainty about future demand for COVID-19 vaccines continues, though, look for continued volatility with all of these stocks.</p><p><blockquote>不过，只要COVID-19疫苗未来需求的不确定性持续存在，所有这些股票都将持续波动。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.fool.com/investing/2021/09/28/why-pfizer-biontech-moderna-and-novavax-stocks-are/\">Motley Fool</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNTX":"BioNTech SE","PFE":"辉瑞","MRNA":"Moderna, Inc.","NVAX":"诺瓦瓦克斯医药"},"source_url":"https://www.fool.com/investing/2021/09/28/why-pfizer-biontech-moderna-and-novavax-stocks-are/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1111572816","content_text":"Investors seem increasingly jittery about the future prospects for COVID-19 vaccines.\n\nKey Points\n\nPfizer, BioNTech SE, and Novavax had some good news Tuesday.\nVaccine stocks are falling, though, probably because of uncertainty about future demand for vaccines.\nIt's still possible that coronavirus variants could drive sustained demand for COVID-19 vaccines.\n\nWhat happened\nThis isn't shaping up to be a good week for the stocks of leading COVID-19 vaccine makers. Several of the stocksslipped on Monday. The downtrend continued Tuesday.\nShares ofPfizer(NYSE:PFE)were down 1.6% at 11:27 a.m.BioNTech(NASDAQ:BNTX)stock had fallen 9.4%.Moderna's(NASDAQ:MRNA)shares were 6.2% lower.Novavax(NASDAQ:NVAX)was an especially big loser, its shares having sunk 11.6%.\nThe declines for these vaccine stocks came despite some good news for several of them. Pfizer and BioNTech submitted initial data to the U.S. Food and Drug Administration from a late-stage study of their COVID-19 vaccine in children younger than 12 years down to age 5. Indian regulators also allowed the Serum Institute of India to begin enrolling kids ages 7 to 11 in a clinical trial evaluating Novavax's COVID-19 vaccine.\nSo why are the stocks falling Tuesday? It's probably because investors are becoming increasingly anxious about the prospects for COVID-19 vaccine sales. The CEOs of both Pfizer and Moderna recently predicted thatthe pandemic could end in 2022.\nAlso, Pfizer announced on Monday that it's started testing a pill that could be used to prevent infection after exposure to another person with COVID-19. If Pfizer's oral drug or similar antiviral therapies become available, it could reduce the incentive for people to seek vaccination.\nSo what\nInvestors absolutely should be looking to the future to evaluate the prospects for vaccine stocks. And there is uncertainty as to whether COVID-19 vaccine sales will remain as strong as they are now in 2023 and beyond.\nIt's not surprising that Pfizer stock didn't fall nearly as much as shares of BioNTech, Moderna, or Novavax. The big drugmaker isn't totally dependent on its COVID-19 vaccine, as BioNTech and Moderna are -- and Novavax potentially soon will be.\nHowever, there's still a possibility that emerging coronavirus variants could cause the demand for COVID-19 vaccines to remain strong for years to come. Tuesday's sell-off could turn out to be unwarranted.\nNow what\nEach of these stocks has key catalysts on the way. Pfizer and BioNTech hope to soon file for FDA Emergency Use Authorization for their COVID-19 vaccine in immunizing younger children. Moderna awaits a decision on booster doses. Novavax hopes to win Emergency Use Listing from the World Health Organization for its COVID-19 vaccine and plans to file for EUAs in multiple countries.\nAs long as the uncertainty about future demand for COVID-19 vaccines continues, though, look for continued volatility with all of these stocks.","news_type":1,"symbols_score_info":{"MRNA":0.9,"BNTX":0.9,"NVAX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1651,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":887290821,"gmtCreate":1632038392163,"gmtModify":1632803175129,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[财迷]&nbsp;","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>[财迷]&nbsp;","text":"$Apple(AAPL)$[财迷]","images":[{"img":"https://static.tigerbbs.com/34bc7c3357b72a91eadc2e7430ef4d49","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887290821","isVote":1,"tweetType":1,"viewCount":2187,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":887031433,"gmtCreate":1631941138622,"gmtModify":1632805167516,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"Hdhjs","listText":"Hdhjs","text":"Hdhjs","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/887031433","repostId":"2168717845","repostType":4,"isVote":1,"tweetType":1,"viewCount":911,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887031253,"gmtCreate":1631941116272,"gmtModify":1632805167764,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"up","listText":"up","text":"up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/887031253","repostId":"2168246571","repostType":4,"isVote":1,"tweetType":1,"viewCount":497,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885919873,"gmtCreate":1631750697992,"gmtModify":1631888657591,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"Power","listText":"Power","text":"Power","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885919873","repostId":"2167477590","repostType":4,"isVote":1,"tweetType":1,"viewCount":885,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":885997615,"gmtCreate":1631750235337,"gmtModify":1631883721584,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>up","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>up","text":"$Apple(AAPL)$up","images":[{"img":"https://static.tigerbbs.com/dc9a684259ee5d38212ab2a4b93dd2c8","width":"1080","height":"2259"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/885997615","isVote":1,"tweetType":1,"viewCount":684,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":882351636,"gmtCreate":1631663462825,"gmtModify":1631883821300,"author":{"id":"4089378841570750","authorId":"4089378841570750","name":"BSBGS","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4089378841570750","authorIdStr":"4089378841570750"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>🥰🥰🥰","listText":"<a href=\"https://laohu8.com/S/AAPL\">$Apple(AAPL)$</a>🥰🥰🥰","text":"$Apple(AAPL)$🥰🥰🥰","images":[{"img":"https://static.tigerbbs.com/b1f421d7a91f50077a92f402d0dcb509","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/882351636","isVote":1,"tweetType":1,"viewCount":663,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}